A Real Economy publication

2022 life sciences industry outlook

Feb 09, 2022

Life sciences industry outlook key takeaways

Three key economic drivers are supply chain issues, human capital availability and capital markets.

needle icon

Virtual trial companies are seeing exponential investment growth spurred by increasing clinical trial durations.

stethoscope icon

Despite the small number of approved drugs, cell and gene therapy companies attract a growing amount and proportion of private investment.

#
Life sciences Economics

As the life sciences industry continues to experience growth and new scientific and operational opportunities, it also faces several challenges.

Looking ahead, life sciences companies will encounter increased competition as the economy recovers. This includes competition for experienced and highly skilled talent, as well as for funding and investor interest across the broader economy. We explore what’s happening and what’s to come for this dynamic industry.


Read our sector specific outlooks:


Subscribe to Life Sciences Insights

Knowledge is power. Stay up to date with key life sciences trends and timely insights, delivered straight to your inbox. Update your RSM preferences today. 

The Real Economy

Monthly economic report

A monthly economic report for middle market business leaders.

Industry outlooks

Industry-specific quarterly insights for the middle market.